Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans

Diabetes

Volumn 45, Issue 4, 1996, Pages 454-462

  Lewis, Gary F ^a,b   Zinman, Bernard ^a   Groenewoud, Yolanda ^a   Vranic, Mladen ^a   Giacca, Adria ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; TOLBUTAMIDE;

ADULT; ARTICLE; CONTROLLED STUDY; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLYCOGENOLYSIS; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; LIVER METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029936779     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.4.454     Document Type: Article

References (64)

1. Prager R, Wallace P, Olefsky JM: In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Invest 78:472-481, 1980
2. Cherrington AD, Kawamori R, Pok S, Vranic M: Arginine infusion in dogs model for the roles of insulin and glucagon in regulating glucose turnover and free fatty acid levels. Diabetes 23:805-815, 1974
3. Pilkis SJ, Fox E, Wolfe L, Rothbarth L, Colosia A, Stewart HB, El-Maghrabi MR. Hormonal modulation of key hepatic regulatory enzymes in the gluconeogenic/glycolytic pathway. Ann NY Acad Sci 478:1-19, 1986
4. Coppack SW, Jensen MD, Miles JM. In vivo regulation of lipolysis in humans. J Lipid Res 35:177-193, 1994
5. Freyse EJ, Fischer U, Albrecht G, Marx S, Keilacker H: The effect of prehepatic insulin administration on alanine flux rates in diabetic dogs Diabetologia 30:402-408, 1987
6. Kreisberg RA. Glucose-lactate interrelations in man. N Engl J Med 287:132-137, 1972
7. Consoli A, Nurjhan N, Reilly JJ Jr, Bier DM, Gerich JE Mechanism of increased gluconeogenesis in non insulin-dependent diabetes mellitus: role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism. J Clin Invest 86:2038-2045, 1990
8. Puhakainen I, Koivisto VA, Yki-Jarvinen H: Lipolysis and gluconeogenesis from glycerol are increased in patients with non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 75:789-794, 1992
9. Jahoor F, Peters EJ, Wolfe RR: The relationship between gluconeogenic-substrate supply and glucose production in humans Am J Physiol 258:E288-E296, 1990
10. Consoli A: Role of liver in pathophysiology of NIDDM. Diabetes Care 15:430-441, 1992
11. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA: Effect of fatty acids on glucose production and utilization in man, J Clin Invest 72:1737-1747, 1983
12. Stevenson RW, Williams PE, Cherrington AD: Role of glucagon suppression on gluconeogenesis during insulin treatment of the conscious diabetic dog. Diabetologia 30.782-790, 1987
13. Shafrir E, Bergman M, Felig P: The endocrine pancreas: diabetes mellitus. In Endocrinology and Metabolism. Felig P, Baxter JD, Broadus AE, Frohman LA, Eds. New York, McGraw-Hill, 1987, p. 1043-1178
14. Ader M, Bergman RN: Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol 258:E1020-E1032, 1990
15. Giacca A, Fisher SJ, Shi ZQ, Gupta R, Lickley HLA, Vranic M: Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs. J Clin Invest 90:1769-1777, 1992
16. Prager R, Wallace P, Olefsky JM: Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects. Diabetes 36:607-011, 1987
17. Sindelar DK, Balcom JH, Chu CA, Neal DW, Cherrington AD: Comparison of the effects of a selective increase in artenal or portal insulin on hepatic glucose metabolism (Abstract). Diabetes 43 (Suppl. 1):132A, 1994
18. Rebrin K, Steil GM, Getty L, Bergman RN: Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038-1045, 1995
19. Lewis GF, Steiner G, Polonsky KS, Weller B, Zinman B, A new method for comparing portal versus peripheral venous insulin delivery in humans: tolbutamide versus insulin infusion. J Clin Endocrinol Metab 78:66-70, 1994
20. Lewis GF, Zinman B, Uffelman KD, Szeto L, Weller B, Steiner G: VLDL production is decreased to a similar extent by acute portal vs. peripheral venous insulin. Am J Physiol 267:E566
21. Van Cauter E, Mestrez F, Sturis J, Polonsky KS: Estimation of insulin secretion rates from C-peptide levels: comparison of individual and standard kinetic parameters for C-peptide clearance. Diabeles 41:368-377, 1992
22. Finegood DT, Bergman KN, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic euglycemic glucose clamps: comparison of unlabeled and labeled exogenous infusates Diabetes 36:914-924, 1987
23. Finegood DT, Bergman RN, Vranic M: Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps Diabetes 37:1025-1034, 1988
24. 8H]glucose. Am J Physiol 258:E228-E233, 1990
25. White NH, Skor D, Santiago JV: Practical closed-loop insulin delivery: a system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics Ann Intern Med 97:210-213, 1982
26. Rizza RA, Mandarino LJ, Gerich JE: Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol E630-E639, 1981
27. Finegood DT, Bergman RN: Optimal segments: a method for smoothing tracer data to calculate metabolic fluxes. Am J Physiol 244.E472-E479, 1983
28. Bradley DC, Steil GM, Bergman RN: Quantitation of measurement error with optimal segments basis for adaptive time course smoothing Am J Physiol 264:E902-E911, 1993
29. De Feo P, Perriello G, De Cosmo S, Ventura MM, Campbell PJ, Brunetti P, Gerich JE, Bolli GB: Comparison of glucose counterregulation during ort-term and prolonged hypoglycemia in normal humans. Diabetes 35:563-569, 1986
30. Campra JL, Reynolds TB: The hepatic circulation. In The Liver: Biology and Pathobiology. Arias IM, Popper H, Schachter D, Shafritz DA, Eds. New York, Raven, 1982, p. 627-645
31. Livesey JH, Hodgkinson SC, Roud HR, Donald RA: Effect of time, temperature and freezing on the stability of immunoreactive LH, FSH, TSH, growth hormone, prolactin and insulin in plasma. Clin Biochem 13:151-155, 1980
32. Faber OK, Binder C, Markussen J, Heding LG, Naithani VK, Kuzuya H, Blix P, Horwitz DL, Rubenstein AH: Characterization of seven C-peptide antisera. Diabetes 27 (Suppl. 1):170-177, 1978
33. Bergmann SR, Carlson E, Dannen E, Sobel BE: An improved assay with 4-(2-thiazolylazo)-resorcinol for non-esterified fatty acids in biological fluids. Clin Chim Acta 104:53-63, 1980
34. Lloyd B, Burrin J, Smythe P, Alberti KG: Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-OH-butyrate. Clin Chem 24:1724-1729, 1978
35. Hartling SG, Dinesen B, Kappelgard AM, Faber OK, Binder C: ELISA for human proinsulin. Clin Chim Acta 156:289-297, 1986
36. Stevenson RW, Parsons JA, Alberti KGMM: Effect of intraportal and peripheral insulin on glucose turnover and recycling in diabetic dogs. Am J Physiol 224:E190-E195, 1983
37. Griffen SC, Russell SM, Katz LS, Nicoll CS: Insulin exerts metabolic and growth-promoting effects by a direct action on the liver in vivo: clarification of the functional significance of the portal vascular link between the beta cells of the pancreatic islets and the liver. Proc Natl Acad Sci USA 84:7300-7304, 1987
38. Madison LL, Unger RH: The physiologic significance of the secretion of endogenous insulin into the portal circulation. I. Comparison of the effects of glucagon-free insulin administered via the portal vein and via a peripheral vein on the magnitude of hypoglycemia and peripheral glucose utilization. J Clin Invest 37:631-639, 1958
39. Baruh S: The physiologic significance of portal vs. peripheral injection of insulin in man. Am J Med Sci 269:25-35, 1975
40. Fischer U, Rizza RA, Hall LD, Westland RE, Haymond MW, Clemens AH, Gerich JE, Service FJ: Comparison of peripheral and portal venous insulin administration on postprandial metabolic responses in alloxandiabetic dogs, effects of identical preprogrammed complex insulin infusion waveforms. Diabetes 31:579-584, 1982
41. Ishida T, Chap Z, Chou J, Lewis RM, Hartley CJ, Entman ML, Field JB: Effects of portal and peripheral venous insulin infusion on glucose production and utilization in depancreatized, conscious dogs. Diabetes 33:984-990, 1984
42. Yki-Jarvinen H, Koivisto VA: Natural course of insulin resistance in type I diabetes. N Engl J Med 315:224-230, 1986
43. Bergenstal RM, Dupre J, Lawson PM, Rizza RA, Rubenstein AH: From the KROC Collaborative Study Group: observations on C-peptide and free insulin in the blood during continuous subcutaneous insulin infusion and conventional insulin therapy. Diabetes 39:534-540, 1990
44. Williamson MP, Behme MT, Dupre J, Finegood DT, Grant DR, Zhong R: Portal-caval transposition decreased insulin sensitivity with systemic diversion of pancreatic endocrine secretions (Abstract) Clin Invest Med 15:A40, 1992
45. Lickley HL, Chisholm DJ, Rabinovitch A, Wexler M, Dupre J: Effects of portacaval anastomosis on glucose tolerance in the dog: evidence of an interaction between the gut and the liver in oral glucose disposal. Metabolism 24:1157-1168, 1975
46. Kryshak EJ, Butler PC, Marsh C, Miller A, Barr D, Polonsky K, Perkins KD, Rizza RA: Pattern of postprandial carbohydrate metabolism and effects of portal and peripheral insulin delivery. Diabetes 39:142-148, 1990
47. Dupre J, Grace DM, McDonald TJ, Inculet R, LeBlanc B, Pancreatic endocrine responses to nutrients and bombesin after segmental pancreas autotransplants in dogs. Pancreas 2:99-105, 1987
48. Radziuk J. Barron P, Davies J: The effect of systemic venous drainage of the pancreas on insulin sensitivity in dogs. J Clin Invest 92:1713-1721, 1993
49. Osei K, Henry ML, O'Dorisio TM, Tesi RJ, Sommer BG, Ferguson RM: Physiological and pharmacological stimulation of pancreatic islet hormone secretion in type I diabetic pancreas allograft recipients Diabeles 39:1235-1242, 1990
50. Diem P, Abid M, Kedmon JB, Sutherland DE, Robertson RP: Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes 39:534-540, 1990
51. Wilczek H, Gurnnarsson R, Felig P, Ostman J, Groth CG, Wahren J: Normalization of hepatic glucose regulation despite systemic insulin delivery: studies in patients with pancreatic transplantation for type I (insulin-dependent) diabetes mellitus. Diabetologia 34:345-349, 1991
52. Katz H, Homan M, Velosa J, Robertson P, Rizza R: Effects of pancreas transplantation on postprandial glucose metabolism. N Engl J Med 325:1278-1283, 1991
53. Scharp DW, Lacy PE, Santiago JV, McCullough CS, Weide LG, Boyle PJ, Falqui L, Marchetti P, Ricordi C, Gingerich RL, Jaffe AS, Cryer PE, Hanto DW, Anderson CB, Flye MW: Results of our first 9 intraportal allografts in type I, insulin-dependent diabetes patients. Transplantation 51.76-85, 1991
54. Warnock GL, Kneteman NM, Ryan E, Seelis RE, Rabinovitch A, Rajotte RV: Normoglycemia after transplantation of freely isolated and cryopreserved pancreatic islets in type I (insulin-dependent) diabetes mellitus. Diabetologia 34:5-5-58, 1991
55. Beck-Nielsen H, Hother-Nielsen O, Pedersen O: Mechanism of action of sulphonylureas with special reference to the extrapancreatic effect. an overview. Diabetic Med 5:613-620, 1988
56. Groop LC: Sulfonylureas in NIDDM. Diabetes Care 15:737-754, 1992
57. Zinman B, Ogilvie RI: The acute effects of tolbutamide on forearm metabolism J Clin Endocrinol Metab 35:299-306, 1972
58. Galloway JA, Hooper SA, Spradlin CT, Howey DC, Frank BH, Bowsher RR, Anderson JH: Biosynthetic human proinsulin: review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experience. Diabetes Care 15:666-692, 1992
59. Wahren J, Johansson BL, Wallberg-Henriksson H. Does C-peptide have a physiological role? Diabetologia 37 (Suppl 2):S99-S107, 1994
60. Wojcikowski C, Blackman J, Ostrega D, Lewis G, Galloway J, Rubenstein AH, Polonsky KS: Lack of effect of high-dose biosynthetic C-peptide on pancreatic hormone release in normal subjects. Metabolism 39:827-832, 1990
61. Fisher SJ, Shi ZQ, Lickley HLA, Efendic S, Vranic M, Giacca A: A moderate decline in specific activity does not lead to an underestimation of hepatic glucose production during a glucose clamp. Metabolism. In press
62. Lins PE, Wajngot A, Adamson V, Vranic M, Efendic S: Minimal increases in glucagon level enhance glucose production in man with partial hypoinsulinemia. Diabetes 32:633-636, 1983
63. Myers SR. Diamond MP, Adkins-Marshall BA, Williams PE, Stinsen R, Cherrington AD: Effects of small changes in glucagon on glucose production during a euglycemic hyperinsulinemic clamp. Metabolism 40:66-71, 1991
64. Zuniga-Guajardo S, Zinman B: The metabolic response to the euglycemic insulin clamp in type I diabetes and normal humans. Metabolism 34:926-930, 1985